Diadema Partners LP Reviva Pharmaceuticals Holdings, Inc. Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
A detailed history of Diadema Partners LP transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 650,723 shares of RVPH stock, worth $533,592. This represents 0.16% of its overall portfolio holdings.
Number of Shares
650,723Holding current value
$533,592% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding RVPH
# of Institutions
54Shares Held
6.34MCall Options Held
938KPut Options Held
40.8K-
Vanguard Group Inc Valley Forge, PA1.8MShares$1.48 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$1.26 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$418,4690.03% of portfolio
-
Geode Capital Management, LLC Boston, MA419KShares$343,6930.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY258KShares$211,7210.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $16.8M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...